Benjamin Wunderlich

463 total citations
3 papers, 48 citations indexed

About

Benjamin Wunderlich is a scholar working on Genetics, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Benjamin Wunderlich has authored 3 papers receiving a total of 48 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Genetics, 1 paper in Pathology and Forensic Medicine and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Benjamin Wunderlich's work include Cancer Genomics and Diagnostics (1 paper), Hereditary Neurological Disorders (1 paper) and Myasthenia Gravis and Thymoma (1 paper). Benjamin Wunderlich is often cited by papers focused on Cancer Genomics and Diagnostics (1 paper), Hereditary Neurological Disorders (1 paper) and Myasthenia Gravis and Thymoma (1 paper). Benjamin Wunderlich collaborates with scholars based in Germany, Switzerland and United Kingdom. Benjamin Wunderlich's co-authors include Klemens Ruprecht, Madlen Loebel, Oliver Wengert, Friedemann Paul, Klaus Lenz, Jörg Hofmann, René M. Gieß, Carmen Scheibenbogen, Berit Rosche and Ulf Reimer and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroimmunology and Clinical Chemistry and Laboratory Medicine (CCLM).

In The Last Decade

Benjamin Wunderlich

3 papers receiving 46 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Wunderlich Germany 2 19 18 15 11 9 3 48
D. S. Korobko Russia 5 12 0.6× 32 1.8× 33 2.2× 11 1.0× 5 0.6× 28 65
Katarína Reguliová Czechia 2 5 0.3× 20 1.1× 13 0.9× 4 0.4× 11 1.2× 3 25
Melissa Ortega United States 4 13 0.7× 57 3.2× 24 1.6× 10 0.9× 13 1.4× 11 83
Gavin Brittain United Kingdom 3 20 1.1× 28 1.6× 12 0.8× 12 1.1× 4 0.4× 8 49
Mirza Omari United States 3 15 0.8× 39 2.2× 10 0.7× 4 0.4× 8 0.9× 4 49
Pere Carbonell‐Mirabent Spain 4 8 0.4× 33 1.8× 7 0.5× 7 0.6× 5 0.6× 7 44
Patti Tosta Canada 2 9 0.5× 13 0.7× 8 0.5× 24 2.2× 9 1.0× 2 45
Kyle Hitscherich United States 5 11 0.6× 7 0.4× 20 1.3× 13 1.2× 1 0.1× 14 66
José Luis Sánchez-Menoyo Spain 5 5 0.3× 25 1.4× 17 1.1× 12 1.1× 6 0.7× 9 68
Jodi Haartsen Australia 6 19 1.0× 51 2.8× 9 0.6× 20 1.8× 6 0.7× 10 91

Countries citing papers authored by Benjamin Wunderlich

Since Specialization
Citations

This map shows the geographic impact of Benjamin Wunderlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Wunderlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Wunderlich more than expected).

Fields of papers citing papers by Benjamin Wunderlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Wunderlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Wunderlich. The network helps show where Benjamin Wunderlich may publish in the future.

Co-authorship network of co-authors of Benjamin Wunderlich

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Wunderlich. A scholar is included among the top collaborators of Benjamin Wunderlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Wunderlich. Benjamin Wunderlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Lopez, Juanita, Simon Haefliger, Ruth Plummer, et al.. (2023). Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.. Journal of Clinical Oncology. 41(16_suppl). 2044–2044. 1 indexed citations
2.
Klehmet, Juliane, Stefanie Märschenz, Klemens Ruprecht, et al.. (2018). Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP). Clinical Chemistry and Laboratory Medicine (CCLM). 56(6). 919–926. 12 indexed citations
3.
Ruprecht, Klemens, Benjamin Wunderlich, René M. Gieß, et al.. (2014). Multiple sclerosis: The elevated antibody response to Epstein–Barr virus primarily targets, but is not confined to, the glycine–alanine repeat of Epstein–Barr nuclear antigen-1. Journal of Neuroimmunology. 272(1-2). 56–61. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026